CCL17 and allergic asthma: Since CCL17 and CCL22 are involved in the pathogenesis of atopic diseases, we finally studied the in vivo activity of GPN279 and GPN136 at inhibiting inflammatory cell recruitment in a mouse model of allergic asthma.